News from the FDA/CDC
Revefenacin is a long-acting muscarinic antagonist.
Some 40% of patients making ECSC-related ED visits are treated and discharged home or back to the community.
SAN ANTONIO – In addition to improved pulmonary outcomes, patients playing the harmonica reported improved self-esteem and quality of life.
Nebulizer devices may be a better consideration for some patients.
A new high-flow nasal cannula was studied in comparison with noninvasive ventilation for severe COPD.
From the Journals
The combination of benzodiazepines and opioid use in COPD patients should be avoided.
News From CHEST® Physician
SAN ANTONIO – LABA/LAMA has been found to have cardiovascular benefits in hyperinflated patients with COPD.
SAN ANTONIO - Patients with alcohol abuse or fluid and electrolyte abnormalities also had a higher risk of needing intubation.
SAN ANTONIO - Obese patients with asthma or COPD typically have metabolic and inflammatory profiles that differ from those of nonobese patients...